This module aims to provide an overview of challenges in the early detection and diagnosis of familial hypercholesterolaemia (FH), strategies for screening of FH and the currently available diagnostic scores for FH.
This Continuous Medical Education (CME) is supported by Amgen Biopharmaceuticals Malaysia Sdn Bhd.
You must be a member to access this content.
To become a member, please register here.
If you're already a member, please sign in to access.